Costantini, C. O., Marginea, H., Cristea, E., Tsyshiya, Y., Costa, R. A., Stuckey, T., … Stone, G. W. (2003). Are there any angiographic predictors of abciximab benefit after primary angioplasty for acute myocardial infarction? Analysis from the CADILLAC trial. In AMERICAN JOURNAL OF CARDIOLOGY (Vol. 92, pp. 41L-41L). WASHINGTON, D.C.: EXCERPTA MEDICA INC.

Costantini, C. O., H. Marginea, E. Cristea, Y. Tsyshiya, R. A. Costa, T. Stuckey, M. Turco, et al. “Are there any angiographic predictors of abciximab benefit after primary angioplasty for acute myocardial infarction? Analysis from the CADILLAC trial.” In AMERICAN JOURNAL OF CARDIOLOGY, 92:41L-41L. EXCERPTA MEDICA INC, 2003.

Costantini CO, Marginea H, Cristea E, Tsyshiya Y, Costa RA, Stuckey T, et al. Are there any angiographic predictors of abciximab benefit after primary angioplasty for acute myocardial infarction? Analysis from the CADILLAC trial. In: AMERICAN JOURNAL OF CARDIOLOGY. EXCERPTA MEDICA INC; 2003. p. 41L-41L.

Costantini, C. O., et al. “Are there any angiographic predictors of abciximab benefit after primary angioplasty for acute myocardial infarction? Analysis from the CADILLAC trial.” AMERICAN JOURNAL OF CARDIOLOGY, vol. 92, no. 6A, EXCERPTA MEDICA INC, 2003, pp. 41L-41L.

Costantini CO, Marginea H, Cristea E, Tsyshiya Y, Costa RA, Stuckey T, Turco M, Guagliumi G, Cox DA, Tcheng JE, Grines CL, Griffin JJ, Lansky AJ, Stone GW. Are there any angiographic predictors of abciximab benefit after primary angioplasty for acute myocardial infarction? Analysis from the CADILLAC trial. AMERICAN JOURNAL OF CARDIOLOGY. EXCERPTA MEDICA INC; 2003. p. 41L-41L.